Anticoagulation in congenital heart disease: when and which agent?

Back

ESC Premium Access

Anticoagulation in congenital heart disease: when and which agent?

Session: Give me the evidence in adult congenital heart disease!

Topic: Treatment

Speaker: Professor B. Mulder (Amsterdam, NL)

Event: ESC Congress 2019

Congress Presentation

About the speaker

Professor Barbara Jm Mulder

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))

8 presentations

2 followers

3 more presentations in this session

The evidence for late closure of atrial septal defect

Speaker: Professor H. Baumgartner (Muenster, DE)

Access

Slides

Video

The evidence for operating on coronary anomalies

Speaker: Doctor E. Hickey (Toronto, CA)

Access

Slides

Video

Evidence-based treatment of dilated ascending aorta

Speaker: Professor J. De Backer (Gent, BE)

Access

Slides

Video

Access the full session

Give me the evidence in adult congenital heart disease!

Speakers: Professor B. Mulder, Professor H. Baumgartner, Doctor E. Hickey, Professor J. De Backer

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

Anticoagulation in congenital heart disease: when and which agent?

About the speaker

Professor Barbara Jm Mulder

3 more presentations in this session

The evidence for late closure of atrial septal defect

The evidence for operating on coronary anomalies

Evidence-based treatment of dilated ascending aorta

Access the full session

Give me the evidence in adult congenital heart disease!

About the event

ESC Congress 2019

ESC 365 is supported by